Many studies were published during the last several years on the expression of CCL5 and CCR5 in hematological malignancies, but, only for multiple myeloma (MM) and at least in part for cHL, we have a comprehensive view of the role played by the CCL3-CCL5/CCR5 pair. This evidence concerns the gene CCR5 and Miyoshi myopathy.